Improvement of quantitative microbiological risk assessment (QMRA) methodology through integration with gaenetic data

Sara Arnaboldi1, Elisa Benincà2, Eric G Evers2

  • 1Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) Italy.

Insights

Integrating whole genome sequencing (WGS) data into quantitative microbiological risk assessments (QMRA) can improve accuracy. Key pathogen properties, like virulence, are crucial for linking genetic traits to human health outcomes and enhancing risk estimates.

Area of Science:

  • Microbiology
  • Genomics
  • Risk Assessment

Background:

  • Quantitative microbiological risk assessment (QMRA) estimates pathogen transmission.
  • Whole genome sequencing (WGS) data is increasingly available, offering potential to improve QMRA.
  • Current QMRA methods can be enhanced by integrating genomic information.

Purpose of the Study:

  • To identify key pathogen properties for integrating WGS data into QMRA.
  • To examine the impact of genetic traits on risk estimation for foodborne pathogens.
  • To explore the use of WGS data in refining dose-response models within QMRA.

Main Methods:

  • Analysis of example QMRA for *Listeria monocytogenes*, *Salmonella*, *Campylobacter*, and Shiga toxin-producing *E. coli*.
  • Investigation of genotype-phenotype relationships for pathogen properties.
  • Utilizing genome-wide association studies to correlate genomic traits with clinical symptoms.
  • Incorporating WGS data and genomic traits into a QMRA model for *Listeria monocytogenes*.

Main Results:

  • Virulence of *Listeria monocytogenes* was identified as a key property linking genotypes to human symptoms.
  • WGS data integration, particularly with phenotypic information, enhances QMRA accuracy.
  • Genomic traits can refine the dose-response phase of QMRA models.

Conclusions:

  • WGS data integration significantly improves the reliability of QMRA.
  • Phenotypic information alongside WGS data is crucial for accurate risk assessment.
  • Advancements in OMICS technologies should be incorporated into future risk assessments for better understanding of bacterial subtypes.